Defibrillator Market is to exceed US$ 14 Billion by 2024

Global Defibrillator Market is projected to exceed US$ 14 Billion by the year 2024.
Renub Research report titled “Defibrillator Market Global Forecast, By Product [Implantable Cardioverter Defibrillator, Automated External, Advanced Life Support & Wearable Cardioverter], By End Users (Hospitals, Pre-Hospitals, etc) By Regions (North America, Europe, etc), Companies (Medtronic plc, Boston Scientific, Philips Healthcare, St. Jude Medical, Nihon Kohden Corporation & Zoll Medical Corporation)” provides a complete analysis of Global Defibrillator Market.

Defibrillator is a medical device capable of giving a high energy electric shock to the heart through the chest wall to the patient who has a cardiac arrest. The high energy electric shock is known as defibrillation and is one of the most essential life-saving steps in the process of survival. A number of different defibrillator is available in the market which, include Implanted Defibrillators, Transvenous Defibrillators, External Defibrillators, Wearable Defibrillators and Advanced Life Support Defibrillators. Global Defibrillator Market is projected to exceed US$ 14 Billion by the year 2024.

Defibrillators are used in children, teens, and adults. Medical professionals may recommend defibrillation procedures when a patient’s heart stops functioning or to someone having in life-threatening conditions such as cardiac arrhythmia, ventricular fibrillation, pulseless ventricular tachycardia or to someone who have had a heart attack that has damaged his/her heart’s electrical system. More often, the doctors suggest having an Implantable Cardioverter Defibrillator (ICD) to patients who have survived sudden cardiac arrest (SCA).


Request a free sample copy of the report:

Defibrillators, when used within the first 3-5 minutes of a person having a Sudden Cardiac Arrest (SCA) can significantly increase a victim’s chance of survival from currently what is less 5% to as much as 70% and higher with a defibrillator on the scene. Today, there are defibrillators, which can be used by virtually anyone with little or no experience. Automated defibrillators will analyze patient’s heart rhythm automatically and provide electrical shock to the patient’s heart in order to restore the patient’s normal heart rhythm.



How does an Implantable Cardioverter Defibrillator Work

An implantable cardioverter defibrillator (ICD) has wires having electrodes on the ends to connect ICD to one or more of patient heart’s chambers. These wires carry the electrical signals from patient’s heart to a minicomputer placed in the ICD that monitors the patient heartbeat. If there are any irregularities in the heartbeat, ICD detects the irregularity in no time and initiate a low-energy electrical pulse to prompt patient heart to beat at a normal rate.

These connecting wires of an implantable cardioverter defibrillator (ICD) connect to a small box implanted in patient’s body generally on the chest or abdomen. This small box is fitted with a battery, pulse generator, and a minicomputer. When this minicomputer detects any irregularity in heartbeats, it triggers the ICD’s pulse generator to send electrical pulses which are carried by wires to the patient’s heart.


Client can Purchase this Report in Sections from below link:

Access full Research:

An implantable cardioverter defibrillator (ICD) is also capable of recoding patient’s heart electrical activity and heart rhythms that can help medical professionals to calibrate the programming of patients ICD so that it will work better in order to correct irregular heart rhythms.

An increase in the public funding for healthcare at global level, along with the rising penetration of public and private healthcare insurance is expected to drive the demand of defibrillator globally. In addition; innovative processes such as availability of defibrillators at most of the public places such as shopping malls, train and bus stations, airports and community places in developed countries also anticipated to boost the defibrillator market in the recent future.



Key Topics Covered:

1. Executive Summary

2. Global Defibrillator Market

3. Market Share – Global Defibrillator (2011 – 2024)

3.1 By Product
3.2 By Region

4. By Product – Global Defibrillator Market (2011 – 2024)

4.1 Implantable Cardioverter Defibrillator
4.2 Automated External Defibrillators
4.3 Advanced Life Support Defibrillators
4.4 Wearable Cardioverter Defibrillators

5. By End User – Global Defibrillator Market (2011 – 2024)

5.1 Hospitals
5.2 Pre-Hospitals
5.3 Public Access Market
5.4 Alternate Care Market
5.5 Home Healthcare

6. By Region – Global Defibrillator Market (2011 – 2024)

6.1 North America
6.2 Latin America
6.3 Europe
6.4 Asia-Pacific
6.5 Middle East/Africa (MEA)

7. Company Analysis

7.1 Medtronic
7.2 Boston Scientific
7.3 Philips Healthcare
7.4 St. Jude Medical
7.5 Nihon Kohden Corporation
7.6 Zoll Medical

8. Growth Drivers (Due to data confidentiality, growth drivers have not been disclosed in this table of contents)

8.1 Point No. 1
8.2 Point No. 2

9. Key Challenges (Due to data confidentiality, key challenges have not been disclosed in this table of contents)

9.1 Point No.1



Browse Related Reports : 

Biopsy Devices Market

Ophthalmic Devices Market


Contact Us

Renub Research
Phone: +1-678-302-0700


About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: 6783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States